Form 3 Nexxen International For: Aug 12 Filed by: Johnson Chancelee Roth
http://archive.fast-edgar.com/20260909/A6ZZP22CZ22FP9ZA222I2ZZ46UP3ZZ2IZ782
Filed on: September 9, 2026
Form 6-K GSK plc For: Sep 09
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the
month of September 2026
Commission
File Number 001-15170
GSK plc
(Translation
of registrant's name into English)
79 New Oxford Street, London, WC1A 1DG
(Address
of principal executive office)
Indicate
by check... (continue reading...)
Form 4 STANDEX INTERNATIONAL For: Sep 04 Filed by: Arets Max
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 424B2 JPMORGAN CHASE & CO
The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not
an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
Subject to completion dated September 8, 2026
September , 2026 Registration Statement Nos. 333-293684 and 333-293684-01; Rule 424(b)(2)
Pricing supplement to product supplement no. 3-I dated April... (continue reading...)
Form 424B2 JPMORGAN CHASE & CO
September 4, 2026
Registration Statement Nos. 333-293684 and 333-293684-01; Rule 424(b)(2)
JPMorgan Chase Financial Company LLCStructured Investments
$878,000
Review Notes... (continue reading...)
More SEC Filings
View Older Stories-
Form 144 BRISTOL MYERS SQUIBB CO Filed by: Massacesi Cristian
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 6-K ENI SPA For: Sep 04
-
Form 8-K Barinthus Biotherapeutic For: Sep 09
-
Form S-6 FTP 11
-
Form 8-K NorthWestern Energy Grou For: Sep 09
-
Form 424B2 JPMORGAN CHASE & CO
-
Form S-6 FT 13332
-
Form S-6 FT 13331
-
Form S-6 FT 13330
-
Form S-6 FT 13329
-
Form 424B2 JPMORGAN CHASE & CO
-
Form S-6 FT 13327
-
Form CERT BANK OF MONTREAL /CAN/
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 497J FT 13285
-
Form 144 NIKE, Inc. Filed by: McCartney Philip
-
Form 497J FT 13277
-
Form 40-17G VOLUMETRIC FUND INC
-
Form 424B2 JPMORGAN CHASE & CO
-
Form D Portfolia 2026 SPV 5
-
Form 497J FT 13174
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 BANK OF NOVA SCOTIA
-
Form 497J FT 13173
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 144 Snowflake Inc. Filed by: Kleinerman Christian
-
Form 10-K GREENE COUNTY BANCORP For: Jun 30
-
Form D Asymm Venture Fund II
-
Form S-6/A Invesco Unit Trusts Seri
-
Form 8-K Lexaria Bioscience Corp. For: Sep 07
-
Form D KURTOSYS SYSTEMS INC
-
Form 4 QUAINT OAK BANCORP, INC. For: Sep 05 Filed by: OTT AIMEE K
-
Form 8-K Aspire Biopharma Holding For: Sep 08
-
Form N-CEN AMERICAN BEACON FUNDS For: Jun 30
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 253G2 My Racehorse CA LLC
-
Form 4 QUAINT OAK BANCORP, INC. For: Sep 05 Filed by: GONZALEZ WILLIAM R
-
Form 424B2 BANK OF NOVA SCOTIA
-
Form D/A ITB PREMIUM FUND I LTD
-
Form 424B2 BofA Finance LLC
-
Form FWP HSBC USA INC /MD/ Filed by: HSBC USA INC /MD/
-
Form 8-K Reliance Global Group, For: Sep 02
-
Form 144 LAM RESEARCH CORP Filed by: ARCHER TIMOTHY
-
Form 424B2 TORONTO DOMINION BANK
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 UBS AG
